SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

23 Jan 2026 Evaluate
The sales moved up 30.51% to Rs. 938.83 millions for the December 2025 quarter as compared to Rs. 719.38 millions during the year-ago period.The Profit  for the quarter ended December 2025 of  Rs. 121.29  millions  grew by 63.75% from Rs. 74.07 millions.Operating profit surged to 179.98 millions from the corresponding previous quarter of 121.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 938.83 719.38 30.51 1876.07 1950.75 -3.83 2710.10 3374.56 -19.69
Other Income 3.20 7.46 -57.10 24.41 39.87 -38.78 59.04 167.11 -64.67
PBIDT 179.98 121.45 48.19 219.83 303.55 -27.58 445.60 536.37 -16.92
Interest 11.60 9.86 17.65 30.27 25.09 20.65 37.66 45.01 -16.33
PBDT 168.38 111.59 50.89 189.56 278.46 -31.93 407.94 491.36 -16.98
Depreciation 12.55 13.32 -5.78 36.36 37.60 -3.30 49.99 46.20 8.20
PBT 155.83 98.27 58.57 153.20 240.86 -36.39 357.95 445.16 -19.59
TAX 34.54 24.20 42.73 36.66 58.29 -37.11 89.38 98.79 -9.53
Deferred Tax 2.01 0.48 318.75 4.13 -0.68 -707.35 3.06 -2.03 -250.74
PAT 121.29 74.07 63.75 116.54 182.57 -36.17 268.57 346.37 -22.46
Equity 482.86 482.49 0.08 482.86 482.49 0.08 482.86 482.11 0.16
PBIDTM(%) 19.17 16.88 13.55 11.72 15.56 -24.70 16.44 15.89 3.45

Kopran Share Price

157.10 0.90 (0.58%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×